Loading…
Health Freedom Protection Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Budget/Appropriations
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R. 1148, to establish the Food Safety Administration to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination. H.R. 1344, to improve federal nutrition programs. H.R. 2108/S. 1274, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of food for humans and pets. H.R. 2117, to amend the Federal Food, Drug, and Cosmetic Act concerning foods and dietary supplements. H.R. 2718, to ensure that the goals of DSHEA are met by authorizing appropriations to fully enforce and implement such law. H.R. 2719, to allow amounts paid for foods for special dietary use, dietary supplements, or medical foods be treated as medical exp. H.R. 5069, to require manufacturers to demonstrate sufficient means to cover, for certain products distributed in commerce, costs of potential recalls, and for other purposes; jointly to Energy & Commerce and Agriculture. H.R. 5827, to amend the Federal Food, Drug, and Cosmetic Act to improve food safety; to Energy & Commerce. H.R. 5839, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs; to Energy & Commerce. H.R. 5904, to amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements to improve the safety of food, whether produced and distributed domestically or imported into the United States, by providing for improved information technology to identify high-risk imports and for enhanced capacity in the United States and in foreign governments to identify and address food safety issues on a scientific basis, and for other purposes; to Energy & Commerce. H.R. 6127, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 6270, to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes; jointly to Energy & Commerce and Ways & Means. H. Res. 926, recognizing the importance of food, product safety, and U.S. trade policy; jointly to Ways & Means; Energy & Commerce; and Agriculture. H. R. 1249, to include dehydroepiandrosterone as an anabolic steroid. H.R. 2997, to require the secretary of agriculture and the commissioner of the Food and Drug Administration to establish a program requiring a certificate of assured safety for imported food items. H.R. 3484, to amend the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Federal Food, Drug, and Cosmetic Act to provide for improved public health and food safety through enhanced enforcement, and for other purposes. H.R. 3485, to amend the Federal Food, Drug, and Cosmetic Act, the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Egg Products Inspection Act to improve the safety of food, meat, and poultry products through enhanced traceability, and for other purposes. H.R. 3937, to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of imported food. H.R. 3967, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of imported food. H.R. 6636, to amend the Federal Food, Drug, and Cosmetic Act, the Federal Meat Inspection Act, and the Poultry Products Inspection Act to require that food that contains a genetically-engineered material, or that is produced with a genetically-engineered material, be labeled accordingly. S. 404, to amend the Agricultural Marketing Act of 1946 to require the implementation of country of origin labeling requirements by Sept. 30, 2007. S. 1776, to amend the Federal Food, Drug, and Cosmetic Act to establish a user fee program to ensure food safety, and for other purposes. S. 2245, to establish a commission to ensure food safety in the United States, and for other purposes. S. 2914, to ensure the safety of seafood and seafood products being imported into the United States. S. 3108, to require the president to call a White House conference on food and nutrition; to Agriculture. S. 3385, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply. S. 3409, to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes. S. 3422, to amend the Federal Food, Drug, and Cosmetic Act to provide for the establishment of a traceability system for food, and for other purposes. S. 3575, to amend the Federal Food, Drug, and Cosmetic Act with respect to nutrition labeling of food offered for sale in food service establishments.
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · third_quarter · Food Industry (safety, labeling, etc.)
H.R. 1148, to establish the Food Safety Administration to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination. H.R. 1344, to improve federal nutrition programs. H.R. 2108/S. 1274, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of food for humans and pets. H.R. 2117, to amend the Federal Food, Drug, and Cosmetic Act concerning foods and dietary supplements. H.R. 2718, to ensure that the goals of DSHEA are met by authorizing appropriations to fully enforce and implement such law. H.R. 2719, to allow amounts paid for foods for special dietary use, dietary supplements, or medical foods be treated as medical exp. H.R. 5069, to require manufacturers to demonstrate sufficient means to cover, for certain products distributed in commerce, costs of potential recalls, and for other purposes; jointly to Energy & Commerce and Agriculture. H.R. 5827, to amend the Federal Food, Drug, and Cosmetic Act to improve food safety; to Energy & Commerce. H.R. 5839, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs; to Energy & Commerce. H.R. 5904, to amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements to improve the safety of food, whether produced and distributed domestically or imported into the United States, by providing for improved information technology to identify high-risk imports and for enhanced capacity in the United States and in foreign governments to identify and address food safety issues on a scientific basis, and for other purposes; to Energy & Commerce. H.R. 6127, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 6270, to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes; jointly to Energy & Commerce and Ways & Means. H. Res. 926, recognizing the importance of food, product safety, and U.S. trade policy; jointly to Ways & Means; Energy & Commerce; and Agriculture. H. R. 1249, to include dehydroepiandrosterone as an anabolic steroid. H.R. 2997, to require the secretary of agriculture and the commissioner of the Food and Drug Administration to establish a program requiring a certificate of assured safety for imported food items. H.R. 3484, to amend the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Federal Food, Drug, and Cosmetic Act to provide for improved public health and food safety through enhanced enforcement, and for other purposes. H.R. 3485, to amend the Federal Food, Drug, and Cosmetic Act, the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Egg Products Inspection Act to improve the safety of food, meat, and poultry products through enhanced traceability, and for other purposes. H.R. 3937, to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of imported food. H.R. 3967, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of imported food. H.R. 6636, to amend the Federal Food, Drug, and Cosmetic Act, the Federal Meat Inspection Act, and the Poultry Products Inspection Act to require that food that contains a genetically-engineered material, or that is produced with a genetically-engineered material, be labeled accordingly. S. 404, to amend the Agricultural Marketing Act of 1946 to require the implementation of country of origin labeling requirements by Sept. 30, 2007. S. 1776, to amend the Federal Food, Drug, and Cosmetic Act to establish a user fee program to ensure food safety, and for other purposes. S. 2245, to establish a commission to ensure food safety in the United States, and for other purposes. S. 2914, to ensure the safety of seafood and seafood products being imported into the United States. S. 3108, to require the president to call a White House conference on food and nutrition; to Agriculture. S. 3385, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply. S. 3409, to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes. S. 3422, to amend the Federal Food, Drug, and Cosmetic Act to provide for the establishment of a traceability system for food, and for other purposes. S. 3575, to amend the Federal Food, Drug, and Cosmetic Act with respect to nutrition labeling of food offered for sale in food service establishments.
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
Legislation and regulations afecting the advertising, marketing and promotion of goods and services | Food Advertising | Prescription Drug Advertising | Children's Advertising | S.334 Healthy Americans Act | S.484 Enhancing Drug Safety and Innovation Act | S. 468 FDA Safety Act | HR 1561 Enhancing Drug Safety and Innovation Act | HR 2117 Health Freedom Protection Act | S 2311 Nonprescription Drug Modernization Act | S 100 Health Students Act | S 948 CAMRA Act |
Client expense: $75,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Food Industry (safety, labeling, etc.)
H.R. 1148, to establish the Food Safety Administration to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination. H.R. 1344, to improve federal nutrition programs. H.R. 2108/S. 1274, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of food for humans and pets. H.R. 2117, to amend the Federal Food, Drug, and Cosmetic Act concerning foods and dietary supplements. H.R. 2718, to ensure that the goals of DSHEA are met by authorizing appropriations to fully enforce and implement such law. H.R. 2719, to allow amounts paid for foods for special dietary use, dietary supplements, or medical foods be treated as medical exp. H.R. 5069, to require manufacturers to demonstrate sufficient means to cover, for certain products distributed in commerce, costs of potential recalls, and for other purposes; jointly to Energy & Commerce and Agriculture. H.R. 5827, to amend the Federal Food, Drug, and Cosmetic Act to improve food safety; to Energy & Commerce. H.R. 5839, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs; to Energy & Commerce. H.R. 5904, to amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements to improve the safety of food, whether produced and distributed domestically or imported into the United States, by providing for improved information technology to identify high-risk imports and for enhanced capacity in the United States and in foreign governments to identify and address food safety issues on a scientific basis, and for other purposes; to Energy & Commerce. H.R. 6127, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 6270, to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes; jointly to Energy & Commerce and Ways & Means. H. Res. 926, recognizing the importance of food, product safety, and U.S. trade policy; jointly to Ways & Means; Energy & Commerce; and Agriculture. H. R. 1249, to include dehydroepiandrosterone as an anabolic steroid. H.R. 2997, to require the secretary of agriculture and the commissioner of the Food and Drug Administration to establish a program requiring a certificate of assured safety for imported food items. H.R. 3484, to amend the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Federal Food, Drug, and Cosmetic Act to provide for improved public health and food safety through enhanced enforcement, and for other purposes. H.R. 3485, to amend the Federal Food, Drug, and Cosmetic Act, the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Egg Products Inspection Act to improve the safety of food, meat, and poultry products through enhanced traceability, and for other purposes. H.R. 3937, to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of imported food. H.R. 3967, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of imported food. H.R. 6636, to amend the Federal Food, Drug, and Cosmetic Act, the Federal Meat Inspection Act, and the Poultry Products Inspection Act to require that food that contains a genetically-engineered material, or that is produced with a genetically-engineered material, be labeled accordingly. S. 404, to amend the Agricultural Marketing Act of 1946 to require the implementation of country of origin labeling requirements by Sept. 30, 2007. S. 1776, to amend the Federal Food, Drug, and Cosmetic Act to establish a user fee program to ensure food safety, and for other purposes. S. 2245, to establish a commission to ensure food safety in the United States, and for other purposes. S. 2914, to ensure the safety of seafood and seafood products being imported into the United States. S. 3108, to require the president to call a White House conference on food and nutrition; to Agriculture. S. 3385, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply. S. 3409, to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes. S. 3422, to amend the Federal Food, Drug, and Cosmetic Act to provide for the establishment of a traceability system for food, and for other purposes. S. 3575, to amend the Federal Food, Drug, and Cosmetic Act with respect to nutrition labeling of food offered for sale in food service establishments.
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Food Industry (safety, labeling, etc.)
H.R. 1148, to establish the Food Safety Administration to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination. H.R. 1344, to improve federal nutrition programs. H.R. 2108/S. 1274, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of food for humans and pets. H.R. 2117, to amend the Federal Food, Drug, and Cosmetic Act concerning foods and dietary supplements. H.R. 2718, to ensure that the goals of DSHEA are met by authorizing appropriations to fully enforce and implement such law. H.R. 2719, to allow amounts paid for foods for special dietary use, dietary supplements, or medical foods be treated as medical exp. H.R. 5069, to require manufacturers to demonstrate sufficient means to cover, for certain products distributed in commerce, costs of potential recalls, and for other purposes; jointly to Energy & Commerce and Agriculture. H.R. 5827, to amend the Federal Food, Drug, and Cosmetic Act to improve food safety; to Energy & Commerce. H.R. 5839, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs; to Energy & Commerce. H.R. 5904, to amend the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements to improve the safety of food, whether produced and distributed domestically or imported into the United States, by providing for improved information technology to identify high-risk imports and for enhanced capacity in the United States and in foreign governments to identify and address food safety issues on a scientific basis, and for other purposes; to Energy & Commerce. H.R. 6127, to require the president to call a White House conference on food and nutrition; to Agriculture. H.R. 6270, to amend the Federal Food, Drug, and Cosmetic Act to create a new conditional approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients, and for other purposes; jointly to Energy & Commerce and Ways & Means. H. Res. 926, recognizing the importance of food, product safety, and U.S. trade policy; jointly to Ways & Means; Energy & Commerce; and Agriculture. H. R. 1249, to include dehydroepiandrosterone as an anabolic steroid. H.R. 2997, to require the secretary of agriculture and the commissioner of the Food and Drug Administration to establish a program requiring a certificate of assured safety for imported food items. H.R. 3484, to amend the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Federal Food, Drug, and Cosmetic Act to provide for improved public health and food safety through enhanced enforcement, and for other purposes. H.R. 3485, to amend the Federal Food, Drug, and Cosmetic Act, the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Egg Products Inspection Act to improve the safety of food, meat, and poultry products through enhanced traceability, and for other purposes. H.R. 3937, to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of imported food. BURGESS: H.R. 3967, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of imported food. S. 404, to amend the Agricultural Marketing Act of 1946 to require the implementation of country of origin labeling requirements by Sept. 30, 2007. S. 1776, to amend the Federal Food, Drug, and Cosmetic Act to establish a user fee program to ensure food safety, and for other purposes. S. 2245, to establish a commission to ensure food safety in the United States, and for other purposes. S. 2914, to ensure the safety of seafood and seafood products being imported into the United States; to Health, Education, Labor, & Pensions. S. 3108, to require the president to call a White House conference on food and nutrition; to Agriculture.
2008 · second_quarter · Advertising
Food Advertising; Prescription Drug Advertising; Children's Advertising; S.334 Healthy Americans Act; S.484 Enhancing Drug Safety and Innovation Act of 2007; S.468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; HR 2117 Health Freedom Protection Act; S 2311 Nonprescription Drug Modernization Act; HR 4083 Nonprescription Drug Modernization Act; S 100 Healthy Students Act of 2007; S 948 CAMRA Act; S. 1031; HR 2045; HR 2633;
Client expense: $75,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Budget/Appropriations
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008, H.R.5605 Physician Payments Sunshine Act of 2008, S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Food Industry (safety, labeling, etc.)
H.R. 1148, to establish the Food Safety Administration to protect the public health by preventing food-borne illness, ensuring the safety of food, improving research on contaminants leading to food-borne illness, and improving security of food from intentional contamination. H.R. 1344, to improve federal nutrition programs. H.R. 2108/S. 1274, to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of food for humans and pets. H.R. 2117, to amend the Federal Food, Drug, and Cosmetic Act concerning foods and dietary supplements. H.R. 2718, to ensure that the goals of DSHEA are met by authorizing appropriations to fully enforce and implement such law. H.R. 2719, to allow amounts paid for foods for special dietary use, dietary supplements, or medical foods be treated as medical exp. H.R. 5069, to require manufacturers to demonstrate sufficient means to cover, for certain products distributed in commerce, costs of potential recalls, and for other purposes; jointly to Energy & Commerce and Agriculture. H. Res. 926, recognizing the importance of food, product safety, and U.S. trade policy; jointly to Ways & Means; Energy & Commerce; and Agriculture. H. R. 1249, to include dehydroepiandrosterone as an anabolic steroid. H.R. 2997, to require the secretary of agriculture and the commissioner of the Food and Drug Administration to establish a program requiring a certificate of assured safety for imported food items. H.R. 3484, to amend the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Federal Food, Drug, and Cosmetic Act to provide for improved public health and food safety through enhanced enforcement, and for other purposes. H.R. 3485, to amend the Federal Food, Drug, and Cosmetic Act, the Federal Meat Inspection Act, the Poultry Products Inspection Act, and the Egg Products Inspection Act to improve the safety of food, meat, and poultry products through enhanced traceability, and for other purposes. H.R. 3937, to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of imported food. BURGESS: H.R. 3967, to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of imported food. S. 404, to amend the Agricultural Marketing Act of 1946 to require the implementation of country of origin labeling requirements by Sept. 30, 2007. S. 1776, to amend the Federal Food, Drug, and Cosmetic Act to establish a user fee program to ensure food safety, and for other purposes. S. 2245, to establish a commission to ensure food safety in the United States, and for other purposes.
2008 · first_quarter · Advertising
S.334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act; S. 2311 Nonprescription Drug Modernization Act; HR. 4083 Nonprescription Drug Modernizaion Act; S 100 Healthy Students Act of 2007; S. 948 CAMRA Act; S. 1031; S. 1342; H.R. 1224 ; H.R. 2045; H.R. 2633; H.R. 2278; H.R. 2419
Client expense: $80,000 · Firm income: Not reported
2008 · first_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $10,000
2008 · first_quarter · Budget/Appropriations
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: Not reported · Firm income: $20,000
2008 · first_quarter · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
2008 · first_quarter · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
2008 · first_quarter · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2008 · first_quarter · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
2008 · first_quarter · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
| Republican |
| TN |
| John Kuhl | Republican | NY |
| Luis Fortuño | Republican | PR |
| Marilyn Musgrave | Republican | CO |
| Peter A. DeFazio | Democratic | OR |
| Roscoe G. Bartlett | Republican | MD |
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Client expense: $110,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Client expense: $90,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)